Cyclacel Pharmaceuticals

Yahoo Finance • 19 days ago

Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.

KUALA LUMPUR, Malaysia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (Nasdaq: BGMS, Nasdaq: BGMSP) (“Bio Green Med” or the “Company”), a company engaged in diversified industries, today announced that it has closed the... Full story

Yahoo Finance • 20 days ago

Oversold Conditions For Brown & Brown (BRO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 2 months ago

Cyclacel Pharmaceuticals declares $0.15 dividend

* Cyclacel Pharmaceuticals (NASDAQ:CYCC [https://seekingalpha.com/symbol/CYCC]) declares $0.15/share quarterly dividend [https://seekingalpha.com/pr/20200145-cyclacel-pharmaceuticals-reports-second-quarter-financial-results-and-provides-... Full story

Yahoo Finance • 2 months ago

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

KUALA LUMPUR, Malaysia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced its second... Full story

Yahoo Finance • 2 months ago

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

- Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA LUMPUR, Malaysia, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Co... Full story

Yahoo Finance • 2 months ago

Get insights into the top gainers and losers of Thursday's pre-market session.

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. [premarket] GAINERS TICKER CHANGE COMMENT LIDR [https://www.chartmill.com/st... Full story

Yahoo Finance • 3 months ago

Cyclacel stock falls after paring 270% gain amid volatility concerns

Investing.com -- Cyclacel Pharmaceuticals , Inc. (NASDAQ:CYCC) stock fell 14% on Wednesday morning, giving back some of its massive 270% gain from the previous session as the company addressed recent stock price volatility. The biopharma... Full story

Yahoo Finance • 3 months ago

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.98%

Investing.com – U.S. stocks were mixed after the close on Tuesday, as gains in the Technology, Telecoms and Industrials sectors led shares higher while losses in the Basic Materials, Healthcare and Financials sectors led shares lower. At... Full story

Yahoo Finance • 3 months ago

Cyclacel stock soars after amendment to exchange agreement with FITTERS

Investing.com -- Cyclacel Pharmaceuticals , Inc. (NASDAQ:CYCC) stock surged 50% after announcing an amendment to its exchange agreement with Malaysian investment holding company FITTERS Diversified Berhad (KL:9318). The biopharmaceutical... Full story

Yahoo Finance • 3 months ago

Cyclacel Pharmaceuticals announces 1-for-15 reverse stock split

Cyclacel Pharmaceuticals (CYCC) announced that it expects to implement a 1-for-15 reverse stock split on its shares of common stock effective July 7, 2025, with trading to begin on a split-adjusted basis at the market open on that day. Tra... Full story

Yahoo Finance • 3 months ago

Cyclacel Pharmaceuticals Announces Stock Split

Cyclacel BERKELEY HEIGHTS, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced tha... Full story

Yahoo Finance • 3 months ago

Cyclacel Pharmaceuticals shareholders re-elect directors and approve equity plan changes

Cyclacel Pharmaceuticals , Inc. (NASDAQ:CYCC), currently trading at $0.33 per share with a market capitalization of $7.29 million, held its 2025 annual meeting of shareholders on June 30, 2025, according to a statement based on a recent SE... Full story

Yahoo Finance • 3 months ago

Cyclacel raises $3M in private placement

* Cyclacel Pharmaceuticals (NASDAQ:CYCC [https://seekingalpha.com/symbol/CYCC]) has raised $3M through a private placement of convertible Series F Preferred Stock, issuing warrants to purchase up to 9.81M common shares at prices between... Full story